ELA-32(human) TFA Catalog No.:M16934-C DDO-2093 selectively inhibits the catalytic

DDO-2093 selectively inhibits the catalytic activity of MLL complex

Formula: C59H71ClFN11O7S

Formula: C30H44O3

and platelet aggregation

ELA-32(human) TFA Catalog No.:M16934-C DDO-2093 selectively inhibits the catalyticELA 32(human) TFA is a potent, high affinity apelin receptor agonist (IC50=0. 27 nM; Kd=0. 51 nM). ELA 32(human) TFA exhibits no binding GPR15 and GPR25. ELA 32(human) TFA activates the PI3K AKT pathway and promotes self renewal of hESCs via cell cycle progression and protein translation. ELA 32(human) TFA also potentiates the TGF pathway, priming hESCs toward the endoderm lineage. ELA 32(human) TFA stimulates angiogenesis in HUVEC cells. Product